相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Sertraline use during pregnancy and the risk of major malformations
Anick Berard et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2015)
Maternal Antidepressant Use and Persistent Pulmonary Hypertension of the Newborn Reply
Krista F. Huybrechts et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Exposure to selective serotonin reuptake inhibitors during pregnancy and risk of autism spectrum disorder in children: A systematic review and meta-analysis of observational studies
Kenneth K. C. Man et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2015)
Prenatal exposure to serotonin reuptake inhibitor antidepressants and childhood behavior
Gillian E. Hanley et al.
PEDIATRIC RESEARCH (2015)
Maternal psychiatric disease and epigenetic evidence suggest a common biology for poor fetal growth
Timothy H. Ciesielski et al.
BMC PREGNANCY AND CHILDBIRTH (2015)
Specific SSRIs and birth defects: bayesian analysis to interpret new data in the context of previous reports
Jennita Reefhuis et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Specific SSRIs and birth defects: bayesian analysis to interpret new data in the context of previous reports
Jennita Reefhuis et al.
BMJ-BRITISH MEDICAL JOURNAL (2015)
Prenatal antidepressant exposure is associated with risk for attention-deficit hyperactivity disorder but not autism spectrum disorder in a large health system
C. C. Clements et al.
MOLECULAR PSYCHIATRY (2015)
Use of SSRI and SNRI Antidepressants during Pregnancy: A Population-Based Study from Denmark, Iceland, Norway and Sweden
Helga Zoega et al.
PLOS ONE (2015)
The effect of perinatal exposures on the infant: Antidepressants and depression
Gillian E. Hanley et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2014)
Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study
L. Ban et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2014)
Prenatal exposure to selective serotonin reuptake inhibitors and social responsiveness symptoms of autism: population-based study of young children
Hanan El Marroun et al.
BRITISH JOURNAL OF PSYCHIATRY (2014)
Use of Selective Serotonin-Reuptake Inhibitors During Pregnancy and the Risk of Clubfoot
Mahsa M. Yazdy et al.
EPIDEMIOLOGY (2014)
Rate of Chiari I Malformation in Children of Mothers with Depression with and without Prenatal SSRI Exposure
Rebecca C. Knickmeyer et al.
NEUROPSYCHOPHARMACOLOGY (2014)
Antidepressant Use in Pregnancy and the Risk of Cardiac Defects
Krista F. Huybrechts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Treating Perinatal Depression Risks and Stigma
Samantha Meltzer-Brody
OBSTETRICS AND GYNECOLOGY (2014)
Exposure to Selective Serotonin Reuptake Inhibitors in Early Pregnancy and the Risk of Miscarriage
Jon Traerup Andersen et al.
OBSTETRICS AND GYNECOLOGY (2014)
Prenatal SSRI Use and Offspring With Autism Spectrum Disorder or Developmental Delay
Rebecca A. Harrington et al.
PEDIATRICS (2014)
In Utero Exposure to Selective Serotonin Reuptake Inhibitors and Risk for Autism Spectrum Disorder
Nicole B. Gidaya et al.
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS (2014)
Systematic meta-analysis of individual selective serotonin reuptake inhibitor medications and congenital malformations
Nicholas Myles et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2013)
Serotonin Hypothesis of Autism: Implications for Selective Serotonin Reuptake Inhibitor Use during Pregnancy
Rebecca A. Harrington et al.
AUTISM RESEARCH (2013)
Identifying Associations between Maternal Medication Use and Birth Defects Using a Case-Population Approach: An Exploratory Study on Signal Detection
Linda de Jonge et al.
DRUG SAFETY (2013)
Infant developmental outcomes following prenatal exposure to antidepressants, and maternal depressed mood and positive affect
Gillian E. Hanley et al.
EARLY HUMAN DEVELOPMENT (2013)
Cardiovascular mechanisms of SSRI drugs and their benefits and risks in ischemic heart disease and heart failure
Andrade Chittaranjan et al.
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY (2013)
Selective Serotonin Reuptake Inhibitors During Pregnancy and Risk of Stillbirth and Infant Mortality
Olof Stephansson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Use of Selective Serotonin Reuptake Inhibitors during Pregnancy and Risk of Autism
Anders Hviid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Prenatal Antidepressant Exposure and Risk of Spontaneous Abortion - A Population-Based Study
Maiken Ina Siegismund Kjaersgaard et al.
PLOS ONE (2013)
Use of Antidepressant Medication in the United States During Pregnancy, 2002-2010
Matthew Ryan Meunier et al.
PSYCHIATRIC SERVICES (2013)
Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study
Dheeraj Rai et al.
BMJ-BRITISH MEDICAL JOURNAL (2013)
Antidepressant exposure in pregnancy and risk of autism spectrum disorders
Merete Juul Sorensen et al.
Clinical Epidemiology (2013)
Pathophysiology, management, and outcome of persistent pulmonary hypertension of the newborn: a clinical review
Mohammed Puthiyachirakkal et al.
FRONTIERS IN PEDIATRICS (2013)
The Use of Central Nervous System Active Drugs During Pregnancy
Bengt Kallen et al.
PHARMACEUTICALS (2013)
Pregnancy Outcomes Following Use of Escitalopram: A Prospective Comparative Cohort Study
Chagit Klieger-Grossmann et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2012)
Pregnancy Outcome After Exposure to Antidepressants and the Role of Maternal Depression Results From the Norwegian Mother and Child Cohort Study
Hedvig Nordeng et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2012)
Exposure to selective serotonin reuptake inhibitors and the risk of congenital malformations: a nationwide cohort study
Espen Jimenez-Solem et al.
BMJ OPEN (2012)
First-degree relatives of young children with autism spectrum disorders: Some gender aspects
Mats Anders Eriksson et al.
RESEARCH IN DEVELOPMENTAL DISABILITIES (2012)
Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: population based cohort study from the five Nordic countries
Helle Kieler et al.
BRITISH MEDICAL JOURNAL (2012)
Medication use during pregnancy, with particular focus on prescription drugs: 1976-2008
Allen A. Mitchell et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2011)
Persistent Pulmonary Hypertension of the Newborn Is Associated with Mode of Delivery and Not with Maternal Use of Selective Serotonin Reuptake Inhibitors
Karen L. Wilson et al.
AMERICAN JOURNAL OF PERINATOLOGY (2011)
Antidepressant Use During Pregnancy and Childhood Autism Spectrum Disorders
Lisa A. Croen et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Dispensing Patterns and Pregnancy Outcomes for Women Dispensed Selective Serotonin Reuptake Inhibitors in Pregnancy
Lyn Colvin et al.
BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY (2011)
The Case-Population Study Design An Analysis of its Application in Pharmacovigilance
Helene Theophile et al.
DRUG SAFETY (2011)
Patterns of Antidepressant Medication Use Among Pregnant Women in a United States Population
Sura Alwan et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Selective Serotonin Reuptake Inhibitors Affect Neurobehavioral Development in the Human Fetus
Eduard J. H. Mulder et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Selective Serotonin Reuptake Inhibitors and Risk for Major Congenital Anomalies
Heli Malm et al.
OBSTETRICS AND GYNECOLOGY (2011)
Third Trimester Fetal Heart Rate and Doppler Middle Cerebral Artery Blood Flow Velocity Characteristics During Prenatal Selective Serotonin Reuptake Inhibitor Exposure
Dan Rurak et al.
PEDIATRIC RESEARCH (2011)
A Meta-analysis of Depression During Pregnancy and the Risk of Preterm Birth, Low Birth Weight, and Intrauterine Growth Restriction
Nancy K. Grote et al.
ARCHIVES OF GENERAL PSYCHIATRY (2010)
Use of antidepressants during pregnancy and the risk of spontaneous abortion
Hamid Reza Nakhai-Pour et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2010)
Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data
M. Reis et al.
PSYCHOLOGICAL MEDICINE (2010)
Gestational Exposure to Antidepressants and the Risk of Spontaneous Abortion: A Review
Perrine Broy et al.
Current Drug Delivery (2010)
Are Selective Serotonin Reuptake Inhibitors Cardiac Teratogens? Echocardiographic Screening of Newborns with Persistent Heart Murmur
Paul Merlob et al.
BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY (2009)
Incidence of Major Malformations in Infants Following Antidepressant Exposure in Pregnancy: Results of a Large Prospective Cohort Study
Adrienne Einarson et al.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE (2009)
Fetal Effects of Psychoactive Drugs
Amy L. Salisbury et al.
CLINICS IN PERINATOLOGY (2009)
Association Between Diabetes and Perinatal Depression Among Low-Income Mothers
Katy Backes Kozhimannil et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Congenital Heart Disease Associated With Selective Serotonin Reuptake Inhibitor Use During Pregnancy
Christina L. Wichman et al.
MAYO CLINIC PROCEEDINGS (2009)
Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn
Susan E. Andrade et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2009)
Selective serotonin reuptake inhibitors in pregnancy and congenital malformations: population based cohort study
Lars Henning Pedersen et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Use of antidepressant medications during pregnancy: a multisite study
Susan E. Andrade et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2008)
Major congenital malformations following prenatal exposure to serotonin reuptake inhibitors and benzodiazepines using population-based health data
Tim F. Oberlander et al.
BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY (2008)
Psychosocial stress and pregnancy outcome
Calvin J. Hobel et al.
CLINICAL OBSTETRICS AND GYNECOLOGY (2008)
Neonatal outcome following pregnancy exposure to antidepressants: a prospective controlled cohort study
S. Maschi et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2008)
Risks of congenital malformations and perinatal events among infants exposed to antidepressant medications during pregnancy
Robert L. Davis et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Paroxetine in the first trimester and the prevalence of congenital malformations
J. Alexander Cole et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2007)
Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth
Rita Suri et al.
AMERICAN JOURNAL OF PSYCHIATRY (2007)
Birth outcomes following prenatal exposure to antidepressants
Kimberly H. Pearson et al.
JOURNAL OF CLINICAL PSYCHIATRY (2007)
Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects
Sura Alwan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects
Carol Louik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations
Bengt A. J. Kallen et al.
BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY (2007)
First trimester exposure to paroxetine and risk of cardiac malformations in infants:: The importance of dosage
Anick Berard et al.
BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY (2007)
Externalizing and attentional behaviors in children of depressed mothers treated with a selective serotonin reuptake inhibitor antidepressant during pregnancy
Tim F. Oberlander et al.
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE (2007)
To treat or not to treat: maternal depression, SSRI use in pregnancy and adverse neonatal effects
Marie-Paule Austin
PSYCHOLOGICAL MEDICINE (2006)
Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health data
Tim F. Oberlander et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Prenatal depression effects on the fetus and newborn: a review
Tiffany Field et al.
INFANT BEHAVIOR & DEVELOPMENT (2006)
Selective serotonin reuptake inhibitors and adverse pregnancy outcomes
SW Wen et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2006)
Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn
CD Chambers et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Neonatal abstinence syndrome after in utero exposure to selective serotonin Reuptake inhibitors in term infants
R Levison-Castiel et al.
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE (2006)
Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment
LS Cohen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Risks associated with selective serotonin reuptake inhibitors in pregnancy
H Malm et al.
OBSTETRICS AND GYNECOLOGY (2005)
Drug therapy - The medical management of depression
JJ Mann
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Neonatal outcomes in offspring of women with anxiety and depression during pregnancy
JO Berle et al.
ARCHIVES OF WOMENS MENTAL HEALTH (2005)
Neonatal signs after late in utero exposure to serotonin reuptake inhibitors - Literature review and implications for clinical applications
EL Moses-Kolko et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure
TF Oberlander et al.
PEDIATRICS (2005)
Fluoxetine during pregnancy: impact on fetal development
JL Morrison et al.
REPRODUCTION FERTILITY AND DEVELOPMENT (2005)
Neonate characteristics after maternal use of antidepressants in late pregnancy
B Källén
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE (2004)
Health, sociodemographic data, and pregnancy outcome in women with antepartum depressive symptoms
C Larsson et al.
OBSTETRICS AND GYNECOLOGY (2004)
High antenatal maternal anxiety is related to ADHD symptoms, externalizing problems, and anxiety in 8-and 9-year-olds
BRH Van den Bergh et al.
CHILD DEVELOPMENT (2004)
Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations
K Laine et al.
ARCHIVES OF GENERAL PSYCHIATRY (2003)
Placental passage of antidepressant medications
V Hendrick et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Pharmacokinetics of fluoxetine and norfluoxetine in pregnancy and lactation
T Heikkinen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2003)
Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy
RC Casper et al.
JOURNAL OF PEDIATRICS (2003)
Serotonin and its transporter on proliferation of fetal heart cells
Y Sari et al.
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE (2003)
Outcomes of prenatal antidepressant exposure
GE Simon et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: A prospective, controlled study
I Nulman et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Perinatal outcome following third trimester exposure to paroxetine
AM Costei et al.
ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE (2002)
Citalopram in pregnancy and lactation
T Heikkinen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
Antepartum depressive symptomatology is associated with adverse obstetric and neonatal outcomes
TKH Chung et al.
PSYCHOSOMATIC MEDICINE (2001)
Serotonin and serotonin-like substances as regulators of early embryogenesis and morphogenesis
GA Buznikov et al.
CELL AND TISSUE RESEARCH (2001)
Birth outcomes following prenatal exposure to fluoxetine
LS Cohen et al.
BIOLOGICAL PSYCHIATRY (2000)
Serious life events and congenital malformations: a national study with complete follow-up
D Hansen et al.
LANCET (2000)
Maternal life event stress and congenital anomalies
SL Carmichael et al.
EPIDEMIOLOGY (2000)
分享论文
